Table of Contents

1 Study Coverage

• 1.1 Epinephrine Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Epinephrine Market Size Growth Rate by Product
  • 1.4.2 Epinephrine Auto-injector
  • 1.4.3 Epinephrine Prefilled Syringe
  • 1.4.4 Combination Epinephrine Products
• 1.5 Market by End User
  • 1.5.1 Global Epinephrine Market Size Growth Rate by End User
  • 1.5.2 Anaphylaxis
  • 1.5.3 Cardiac Arrest
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Epinephrine Market Size
  • 2.1.1 Global Epinephrine Revenue 2014-2025
  • 2.1.2 Global Epinephrine Sales 2014-2025
• 2.2 Epinephrine Growth Rate by Regions
  • 2.2.1 Global Epinephrine Sales by Regions
  • 2.2.2 Global Epinephrine Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Epinephrine Sales by Manufacturers
  • 3.1.1 Epinephrine Sales by Manufacturers
  • 3.1.2 Epinephrine Sales Market Share by Manufacturers
  • 3.1.3 Global Epinephrine Market Concentration Ratio (CR5 and HHI)
• 3.2 Epinephrine Revenue by Manufacturers
  • 3.2.1 Epinephrine Revenue by Manufacturers (2014-2019)
  • 3.2.2 Epinephrine Revenue Share by Manufacturers (2014-2019)
• 3.3 Epinephrine Price by Manufacturers
• 3.4 Epinephrine Manufacturing Base Distribution, Product Types
  • 3.4.1 Epinephrine Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Epinephrine Product Type
  • 3.4.3 Date of International Manufacturers Enter into Epinephrine Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Epinephrine Sales by Product
• 4.2 Global Epinephrine Revenue by Product
• 4.3 Epinephrine Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Epinephrine Breakdown Data by End User

6 North America

• 6.1 North America Epinephrine by Countries
  • 6.1.1 North America Epinephrine Sales by Countries
  • 6.1.2 North America Epinephrine Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Epinephrine by Product
• 6.3 North America Epinephrine by End User

7 Europe

• 7.1 Europe Epinephrine by Countries
  • 7.1.1 Europe Epinephrine Sales by Countries
  • 7.1.2 Europe Epinephrine Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Epinephrine by Product
• 7.3 Europe Epinephrine by End User

8 Asia Pacific

• 8.1 Asia Pacific Epinephrine by Countries
  • 8.1.1 Asia Pacific Epinephrine Sales by Countries
  • 8.1.2 Asia Pacific Epinephrine Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Epinephrine by Product
• 8.3 Asia Pacific Epinephrine by End User

9 Central & South America

• 9.1 Central & South America Epinephrine by Countries
  • 9.1.1 Central & South America Epinephrine Sales by Countries
  • 9.1.2 Central & South America Epinephrine Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Epinephrine by Product
• 9.3 Central & South America Epinephrine by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Epinephrine by Countries
  • 10.1.1 Middle East and Africa Epinephrine Sales by Countries
  • 10.1.2 Middle East and Africa Epinephrine Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Epinephrine by Product
• 10.3 Middle East and Africa Epinephrine by End User

11 Company Profiles

• 11.1 Mylan Inc
  • 11.1.1 Mylan Inc Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Mylan Inc Epinephrine Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Mylan Inc Epinephrine Products Offered
  • 11.1.5 Mylan Inc Recent Development
• 11.2 Impax
  • 11.2.1 Impax Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Impax Epinephrine Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Impax Epinephrine Products Offered
  • 11.2.5 Impax Recent Development
• 11.3 ALK Abello
  • 11.3.1 ALK Abello Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 ALK Abello Epinephrine Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 ALK Abello Epinephrine Products Offered
  • 11.3.5 ALK Abello Recent Development
• 11.4 Lincoln Medical Ltd
  • 11.4.1 Lincoln Medical Ltd Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Lincoln Medical Ltd Epinephrine Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Lincoln Medical Ltd Epinephrine Products Offered
  • 11.4.5 Lincoln Medical Ltd Recent Development
• 11.5 Pfizer
  • 11.5.1 Pfizer Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Pfizer Epinephrine Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Pfizer Epinephrine Products Offered
  • 11.5.5 Pfizer Recent Development
• 11.6 Amphastar
  • 11.6.1 Amphastar Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Amphastar Epinephrine Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Amphastar Epinephrine Products Offered
  • 11.6.5 Amphastar Recent Development
• 11.7 Emerade
  • 11.7.1 Emerade Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Emerade Epinephrine Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Emerade Epinephrine Products Offered
  • 11.7.5 Emerade Recent Development
• 11.8 Grand Pharma
  • 11.8.1 Grand Pharma Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Grand Pharma Epinephrine Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Grand Pharma Epinephrine Products Offered
  • 11.8.5 Grand Pharma Recent Development
• 11.9 Harvest Pharmaceuticals
  • 11.9.1 Harvest Pharmaceuticals Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Harvest Pharmaceuticals Epinephrine Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Harvest Pharmaceuticals Epinephrine Products Offered
  • 11.9.5 Harvest Pharmaceuticals Recent Development
• 11.10 Merit Pharmaceutical
  • 11.10.1 Merit Pharmaceutical Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Merit Pharmaceutical Epinephrine Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Merit Pharmaceutical Epinephrine Products Offered
  • 11.10.5 Merit Pharmaceutical Recent Development
• 11.11 Tianjin Jinyao Group

12 Future Forecast

• 12.1 Epinephrine Market Forecast by Regions
  • 12.1.1 Global Epinephrine Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Epinephrine Revenue Forecast by Regions 2019-2025
• 12.2 Epinephrine Market Forecast by Product
  • 12.2.1 Global Epinephrine Sales Forecast by Product 2019-2025
  • 12.2.2 Global Epinephrine Revenue Forecast by Product 2019-2025
• 12.3 Epinephrine Market Forecast by End User
• 12.4 North America Epinephrine Forecast
• 12.5 Europe Epinephrine Forecast
• 12.6 Asia Pacific Epinephrine Forecast
• 12.7 Central & South America Epinephrine Forecast
• 12.8 Middle East and Africa Epinephrine Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Epinephrine Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated epinephrine in 1901.
United States has the largest global export quantity and manufacturers in Epinephrine market, while the Europe is the second sales volume market for Epinephrine in 2017.

In the industry, Mylan Inc profits most in 2016 and recent years, while Impax and ALK Abello ranked 2 and 3.The market share of them is 52.75%, 4.37% and 2.64% in 2017.The gap of market share is keep on enlarged due to different strategy.

Nowadays, there are three mainly types of Epinephrine, including Epinephrine Auto-injector, Epinephrine Prefilled Syringe and Combination Epinephrine Products. And Epinephrine Auto-injector is the main type for Epinephrine, and the Epinephrine Auto-injector reached a sales value of approximately 1430.61 M USD in 2017, with 63.69% of global sales value.

Epinephrine technology is much mature now, and new enterprises can not surpass existing famous brands on reputation or design in the short term. So, the study group recommends the new entrants need to be considered carefully before enter into this field.

The global Epinephrine market is valued at 2250 million US$ in 2018 and will reach 3900 million US$ by the end of 2025, growing at a CAGR of 7.1% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Epinephrine market based on company, product type, end user and key regions.

This report studies the global market size of Epinephrine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Epinephrine in these regions.
This research report categorizes the global Epinephrine market by top players/brands, region, type and end user. This report also studies the global Epinephrine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Mylan Inc
Impax
ALK Abello
Lincoln Medical Ltd
Pfizer
Amphastar
Emerade
Grand Pharma
Harvest Pharmaceuticals
Merit Pharmaceutical
Tianjin Jinyao Group

Market size by Product
Epinephrine Auto-injector
Epinephrine Prefilled Syringe
Combination Epinephrine Products
Market size by End User
Anaphylaxis
Cardiac Arrest
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Epinephrine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Epinephrine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Epinephrine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Epinephrine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Epinephrine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Epinephrine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.